The PRESS Pad

CSIR-IGIB’s CRISPR Gene Therapy Breakthrough for Sickle Cell Disease in India. India has launched its first indigenous CRISPR-based gene therapy  for Sickle Cell Disease (SCD) . The therapy is named BIRSA 101 . The therapy is dedicated to Bhagwan Birsa Munda , a renowned tribal freedom fighter. BIRSA 101  has been developed by the CSIR–Institute of Genomics and Integrative Biology (IGIB) . About Gene Therapy Gene therapy  is a medical technique that uses genes to treat, preve

India has launched its first National Biobank and Longitudinal Health Study, collecting genomic, lifestyle, and clinical data from 10,000 individuals. This data-rich initiative aims to accelerate personalized medicine, AI-driven diagnostics, and indigenous research on diseases like cancer, diabetes, and rare genetic disorders, all rooted in the Indian context.